Cullinan Therapeutics, Inc. (CGEM)

NASDAQ: CGEM · Real-Time Price · USD

13.84

-0.14 (-1.00%)

At close: May 22, 2026, 4:00 PM EDT

14.00

+0.16 (1.16%)

After-hours: May 22, 2026, 4:15 PM EDT

Cullinan Therapeutics Balance Sheet

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Mar '26 Mar 31, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Cash & Equivalents	75.08	88.33	83.01	98.43	156.15	59.77
Short-Term Investments	276.8	289.56	315.97	368.63	311.14	230.69
Cash & Short-Term Investments	351.89	377.9	398.98	467.07	467.29	290.47
Cash Growth	15.82%	-5.28%	-14.58%	-0.05%	60.88%	38.18%
Other Current Assets	9.52	8.86	15.69	13.12	7.18	6.1
Total Current Assets	361.41	386.76	414.67	480.19	474.47	296.56
Net Property, Plant & Equipment	2.78	3.05	2.35	3.53	5.3	0.08
Long-Term Investments	38.5	58.27	204.44	-	80.88	140.4
Other Long-Term Assets	0.3	0.3	0.37	0.46	0.46	0.15
Total Assets	402.98	448.37	621.82	484.18	561.12	437.19
Accounts Payable	2.51	0.84	1.68	2.49	2.66	3.17
Accrued Expenses	31.92	36.12	27.66	24.2	14.14	8.58
Current Portion of Leases	0.73	0.78	1.3	1.44	1.42	-
Other Current Liabilities	-	-	-	-	4.28	-
Total Current Liabilities	35.15	37.74	30.65	28.14	22.5	11.75
Long-Term Leases	1.66	1.9	0.85	2.15	3.59	-
Other Long-Term Liabilities	-	-	-	-	-	0.07
Total Long-Term Liabilities	1.66	1.9	0.85	2.15	3.59	0.07
Total Liabilities	36.81	39.64	31.5	30.29	26.09	11.81
Common Stock	0.01	0.01	0.01	0	0.01	0
Additional Paid-in Capital	1,004	995.82	958.7	654.69	585.32	584.71
Accumulated Other Comprehensive Income	0.13	1.02	-0.13	-0.13	-2.6	-0.84
Retained Earnings	-637.78	-588.12	-368.24	-200.86	-47.7	-158.91
Total Common Shareholders' Equity	366.17	408.73	590.33	453.7	535.03	424.97
Minority Interest	-	-	-	0.19	-	0.4
Shareholders' Equity	366.17	408.73	590.33	453.9	535.03	425.37
Total Liabilities & Equity	402.98	448.37	621.82	484.18	561.12	437.19
Total Debt	2.38	2.68	2.15	3.59	5.01	0
Net Cash (Debt)	349.5	375.21	396.83	463.48	462.28	290.47
Net Cash Growth	-6.85%	-5.45%	-14.38%	0.26%	59.15%	38.18%
Net Cash Per Share	6.85	6.35	7.38	9.71	9.91	6.74
Book Value	366.17	408.73	590.33	453.7	535.03	424.97
Book Value Per Share	7.18	6.92	10.98	9.51	11.47	9.87
Tangible Book Value	366.17	408.73	590.33	453.7	535.03	424.97
Tangible Book Value Per Share	7.18	6.92	10.98	9.51	11.47	9.87

Updated May 7, 2026. Data Source: Fiscal.ai. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q